Advertisement
Advertisement
U.S. Markets close in 3 hrs 19 mins
Advertisement
Advertisement
Advertisement
Advertisement

Maravai LifeSciences Holdings, Inc. (MRVI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.27-0.03 (-0.23%)
As of 12:40PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.30
Open13.21
Bid13.31 x 800
Ask13.32 x 1000
Day's Range12.97 - 13.41
52 Week Range12.16 - 43.50
Volume1,008,698
Avg. Volume2,134,871
Market Cap1.744B
Beta (5Y Monthly)N/A
PE Ratio (TTM)2.82
EPS (TTM)4.71
Earnings DateFeb 21, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est34.33
  • GlobeNewswire

    Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

    Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023 Carl Hull to continue to serve as Executive Chairman and Interim CEO SAN DIEGO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced plans for William “Trey” Martin, III

  • Motley Fool

    2 Biotech Stocks You Can Buy and Hold for the Next Decade

    Oftentimes, investing in early-stage biotech companies can mean seeing a few of your picks lose 95% or even 100% of their value. Drug development is highly risky since it involves creating something new. Let's take a peek at two biotechs that make their money by solving the problems of other biopharma companies.

  • GlobeNewswire

    Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

    SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it ranked 270 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 28th year. "We are honored to be part of this year’s prestigious Fast 500 list, which highligh

Advertisement
Advertisement